GlobalDeal

Abomics Oy

Biotechnology · Helsinki, Finland

abomicspgx.com

About Abomics Oy

Abomics Oy is a Finnish biotechnology company specializing in the development of innovative antibody-based therapeutics. Founded in 2008, the company focuses on harnessing the power of monoclonal antibodies to create targeted treatments for various diseases, including cancer and autoimmune disorders. Abomics Oy employs advanced technologies in antibody engineering and has established collaborations with academic institutions and pharmaceutical companies to enhance its research and development capabilities. The company is committed to improving patient outcomes through the discovery and development of novel therapeutic agents that address unmet medical needs. With a strong emphasis on scientific excellence and innovation, Abomics Oy aims to contribute significantly to the field of biopharmaceuticals.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Therapeutics, Biopharmaceuticals, Antibody Engineering, Research and Development
Location
Helsinki, Finland
Employees
1–10
Revenue (USD)
<1M

Products and services

Open Abomics Oy in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in Finland

All 173 Biotechnology companies in Finland →